Drug intelligence / Profile preview

SYN-AR-C

Development stage
Unknown
Lead developer
FUTRUE
Modality
Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

SYN-AR-C is an oral homeopathic medicinal product developed by FUTRUE R&S 2 GmbH for the treatment of allergic rhinoconjunctivitis (hay fever) caused by grass pollen. It is part of a series of experimental formulations (including SYN-AR-A and SYN-AR-B) investigated in clinical trials to determine the optimal composition for symptom relief. The product utilizes homeopathic dilutions of natural substances to modulate the allergic response and alleviate symptoms such as sneezing, nasal congestion, and itchy eyes. In a Phase 2 randomized, placebo-controlled trial conducted in Germany, SYN-AR-C was evaluated for its efficacy and safety in patients with seasonal allergic rhinitis. The developer, FUTRUE, specializes in natural health and homeopathic OTC products, often utilizing proprietary complexes for respiratory and allergic conditions.

Other names
SYN-AR

Beyond the preview

Go deeper on SYN-AR-C.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SYN-AR-C.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call